OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
April 03, 2021
Topical drugs are attractive to patients, but these complex products pose challenges for formulators.
March 03, 2021
Without an independent approval pathway for novel excipients, true pharmaceutical innovation could be stymied.
Various strategies to improve bioavailability are being continuously evaluated, affording greater commercial prospects for the future.
February 25, 2021
The company will join the network of approved manufacturers of the lipid excipients.
February 10, 2021
The importance of characterizing excipients, supply chain security, and the role of novel excipients are explored.
February 03, 2021
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
December 10, 2020
With the acquisition, Evonik will expand its life science division and its portfolio of functional excipients and biomaterials.
November 04, 2020
At the 2020 Bio/Pharma Virtual Congress, experts discuss the importance of characterizing excipients to ensure quality, safety, and effective performance.
September 02, 2020
Dimethyl sulfoxide is increasingly used in high-risk parenteral and medical device applications that must be manufactured as sterile products in their finished form. A study evaluated the effects four sterilization techniques have on the product quality of this ingredient.